Healthcare Business Resources to acquire GenFlat in reverse merger; GenFlat shareholders get 98% of HBR

GenFlat Holdings, Inc.

HBR to issue 98% of its outstanding shares to GenFlat shareholders in exchange for at least 97.1% of GenFlat stock, making GenFlat a subsidiary.
CEO/director Stephen Epstein and director Howard Wall resign; GenFlat designees assume executive management and board positions.
Closing expected by Dec 31, 2023; remaining GenFlat owners have until Oct 27, 2023 to opt into the share exchange.
GenFlat has 10.3M shares outstanding; HBR has 21.3M shares outstanding (authorized 2.5B common).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.